MTOR and acute myeloid leukemia: Furthermore, it has been demonstrated that the activation of the PI3K/Akt/mTOR axis is a common feature in patients with AML, and inhibition of mTOR blocks the phosphorylation of this kinase and results in cell death in leukemia progenitor cells (14,18–20).